[{"Assets_0_FY_USD":135337000.0,"EarningsPerShareBasic_4_FY_USD":-1.99,"EarningsPerShareDiluted_4_FY_USD":-1.99,"NetIncomeLoss_1_FY_USD":-16674000.0,"NetIncomeLoss_4_FY_USD":-47671000.0,"StockholdersEquity_0_FY_USD":-146973000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":23933309.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":23933309.0,"Ticker":"RETA","CIK":"1358762","name":"REATA PHARMACEUTICALS INC","OfficialName":"Reata Pharmaceuticals Inc. Class A Common Stock","form":"10-K","period":"20171231","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1148907684.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180302"}]